Filing Details
- Accession Number:
- 0001477932-23-004225
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-06-02 18:25:10
- Reporting Period:
- 2022-09-01
- Accepted Time:
- 2023-06-02 18:25:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
924515 | Guided Therapeutics Inc | GTHP | Electromedical & Electrotherapeutic Apparatus (3845) | 582029543 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1365831 | C Michael James | 5835 Peachtree Corners East, Suite B Norcross GA 30092 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2022-09-02 | 100,000 | $0.00 | 112,772 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Warrants | Acquisiton | 2022-09-01 | 100,000 | $0.00 | 100,000 | $0.50 |
Common Stock | Warrants | Acquisiton | 2022-09-01 | 100,000 | $0.00 | 100,000 | $0.65 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
100,000 | 2022-09-01 | 2026-09-01 | No | 4 | P | Direct |
100,000 | 2022-09-01 | 2026-09-01 | No | 4 | P | Direct |
Footnotes
- On September 1, 2022, the Company entered into a Securities Purchase Agreements with Mr. James pursuant to which the Company issued 100,000 shares of its common stock, four year warrants to purchase an aggregate of 100,000 shares of Common Stock at $0.50 per share and 100,000 shares of Common Stock at $0.65 per share for an aggregate purchase price of $50,000.